Abstract
Review of 206 consecutive patients with prostatic carcinoma and a potential for 10 yr followup indicates the efficacy of vigorous surgical or hormonal management. Satisfactory documented followup was achieved in 88% of the group for 5 yr and 82% of the group for 10 yr. Among 33 patients undergoing radical perineal prostatectomy survival rates were 84% at 5 yr and 58% at 10 yr. In the entire series, irrespective of modality of treatment, approximately half of the patients survived 5 yr and a 4th for 10 yr. Hormonal therapy of choice was orchiectomy combined with relatively high doses of estrogens, with no indication of significant cardiovascular morbidity or mortality. Interestingly, stage A disease (often diffuse, anaplastic and unsuspected) demonstrated a significantly increased mortality risk when compared to stage B (localized and usually well differentiated) carcinoma of the prostate.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 323-327 |
| Number of pages | 5 |
| Journal | Journal of Urology |
| Volume | 117 |
| Issue number | 3 |
| State | Published - 1977 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Urology
Cite this
The clinical spectrum of prostate cancer. / deVere White, Ralph W; Paulson, D. F.; Glenn, J. F.
In: Journal of Urology, Vol. 117, No. 3, 1977, p. 323-327.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The clinical spectrum of prostate cancer
AU - deVere White, Ralph W
AU - Paulson, D. F.
AU - Glenn, J. F.
PY - 1977
Y1 - 1977
N2 - Review of 206 consecutive patients with prostatic carcinoma and a potential for 10 yr followup indicates the efficacy of vigorous surgical or hormonal management. Satisfactory documented followup was achieved in 88% of the group for 5 yr and 82% of the group for 10 yr. Among 33 patients undergoing radical perineal prostatectomy survival rates were 84% at 5 yr and 58% at 10 yr. In the entire series, irrespective of modality of treatment, approximately half of the patients survived 5 yr and a 4th for 10 yr. Hormonal therapy of choice was orchiectomy combined with relatively high doses of estrogens, with no indication of significant cardiovascular morbidity or mortality. Interestingly, stage A disease (often diffuse, anaplastic and unsuspected) demonstrated a significantly increased mortality risk when compared to stage B (localized and usually well differentiated) carcinoma of the prostate.
AB - Review of 206 consecutive patients with prostatic carcinoma and a potential for 10 yr followup indicates the efficacy of vigorous surgical or hormonal management. Satisfactory documented followup was achieved in 88% of the group for 5 yr and 82% of the group for 10 yr. Among 33 patients undergoing radical perineal prostatectomy survival rates were 84% at 5 yr and 58% at 10 yr. In the entire series, irrespective of modality of treatment, approximately half of the patients survived 5 yr and a 4th for 10 yr. Hormonal therapy of choice was orchiectomy combined with relatively high doses of estrogens, with no indication of significant cardiovascular morbidity or mortality. Interestingly, stage A disease (often diffuse, anaplastic and unsuspected) demonstrated a significantly increased mortality risk when compared to stage B (localized and usually well differentiated) carcinoma of the prostate.
UR - http://www.scopus.com/inward/record.url?scp=0017347783&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017347783&partnerID=8YFLogxK
M3 - Article
C2 - 839594
AN - SCOPUS:0017347783
VL - 117
SP - 323
EP - 327
JO - Journal of Urology
JF - Journal of Urology
SN - 0022-5347
IS - 3
ER -